TransCode and BRAIN to Co-develop CRISPR-derived Technology Platform for Oncology
TransCode Therapeutics and BRAIN Biotech have entered a joint research and development agreement (JDA) with the objective to co-develop a
Read moreTransCode Therapeutics and BRAIN Biotech have entered a joint research and development agreement (JDA) with the objective to co-develop a
Read moreStemBioSys, Inc. (StemBioSys) announced on Monday, the launch of NeuroMatrix™, an astrocyte-derived extracellular matrix that is developed to enable the
Read morePfizer and BioNTech plan to use mRNA technology to meet the demand for highly effective, well-tolerated, and effectively manufactured shingles
Read moreThe European Union has authorized AstraZeneca’s Forxiga (dapagliflozin) to expand the treatment for heart failure (HF) with reduced ejection fraction
Read moreThe European Commission has authorised Sanofi and Regeneron’s Dupixent® (dupilumab) as the first and only therapeutic therapy for eosinophilic esophagitis.
Read moreThe U.S. Food and Drug Administration (FDA) has approved AstraZeneca and Amgen’s TEZSPIRE® (tezepelumab-ekko) for self-administration in a pre-filled, single-use
Read moreThe acquisition agreement is set to expand Aegis’s toxicology portfolio, while HealthTrackRx expands its PCR infectious disease testing. Aegis Sciences
Read moreLonza and Context Therapeutics, a US-based clinical-stage biopharmaceutical company advancing therapeutics for solid tumors, announced that they have reached a
Read moreThermo Fisher Scientific, the global leader in serving science, announced the launch of the TrueMark Infectious Disease Research Panels designed
Read moreFrench clinical-stage biotech company Sensorion, which focuses on the creation of cutting-edge treatments to manage, prevent, and reverse hearing loss
Read more